**Question:** In pemphigus, autoantibodies are directed against which of the following structures?

A. Desmoglein protein
B. Keratinocytes
C. Desmocollin protein
D. Beta-catenin

**Core Concept:**
Pemphigus is a group of autoimmune diseases characterized by blistering of the skin and mucous membranes due to the formation of autoantibodies targeting specific proteins. In pemphigus, the autoantibodies are directed against proteins that form desmosomes, which are cell-to-cell adhesion structures in the epidermis and mucosal surfaces.

**Why the Correct Answer is Right:**
Desmoglein (DSG) proteins are the key structural components of desmosomes, which are crucial for maintaining epidermal integrity and preventing blistering. In pemphigus, patients produce autoantibodies against desmoglein proteins, specifically desmoglein 1 and desmoglein 3. These autoantibodies disrupt the normal functioning of desmoglein proteins, leading to blistering and erosions.

**Why Each Wrong Option is Incorrect:**

A. Keratinocytes (KC) are the cell type within the epidermis, but they do not form desmosomes, which are the primary targets of autoantibodies in pemphigus. Hence, keratinocytes are not the correct answer.

B. Desmocollin (DCL) proteins are also components of desmosomes, but they are not the primary targets of autoantibodies in pemphigus. Desmoglein proteins are the key components the autoantibodies target.

C. Beta-catenin is a protein involved in cell adhesion, but it is not a key component of desmosomes. Beta-catenin is involved in other cellular processes like Wnt signaling, and autoantibodies in pemphigus specifically target desmoglein proteins.

**Clinical Pearl:**
Desmoglein proteins are crucial for maintaining epidermal integrity and preventing blistering in pemphigus. This understanding of the immune response against these proteins is essential for diagnosing and treating patients with pemphigus, as targeting the correct proteins can lead to effective treatment strategies.